<DOC>
	<DOCNO>NCT02487940</DOCNO>
	<brief_summary>The study include 100 woman unexplained recurrent implantation failure undergo IVF/ICSI cycle . Patients fulfil inclusion criterion randomise two group . Study Group : This group include 50 woman unexplained recurrent implantation failure undergo trial IVF/ICSI . This group receive intravenous infusion intralipid 20 % , day oocyte retrieval , second dose on/ follow day positive pregnancy test final dose 2-3 week later attend pregnancy scan . Control Group : This group include 50 woman unexplained recurrent implantation failure undergo trial IVF/ICSI . This group receive intravenous infusion placebo , day oocyte retrieval , second dose on/ follow day positive pregnancy test final dose 2-3 week later attend pregnancy scan .</brief_summary>
	<brief_title>Assessment Intralipid Efficacy Women With Unexplained Recurrent Implantation Failure</brief_title>
	<detailed_description>The study include 100 woman unexplained recurrent implantation failure undergo IVF/ICSI cycle . Randomisation : Patients fulfil inclusion criterion randomise two group . Study Group : This group include 50 woman unexplained recurrent implantation failure undergo trial IVF/ICSI . This group receive intravenous infusion intralipid 20 % , day oocyte retrieval , second dose on/ follow day positive pregnancy test final dose 2-3 week later attend pregnancy scan . Control Group : This group include 50 woman unexplained recurrent implantation failure undergo trial IVF/ICSI . This group receive intravenous infusion placebo , day oocyte retrieval , second dose on/ follow day positive pregnancy test final dose 2-3 week later attend pregnancy scan . Random allocation sequence generation : A computer generate list use , assign participant number either study group . Allocation Concealment : Assignment do sequentially number , otherwise identical , sealed envelope ( SNOSE ) , contain 2-inch 2-inch paper write code designating assign group . These paper place folded sheet aluminium foil fit inside envelope . Effort take assure absence detectable difference size weight intervention control envelop . Envelopes choose opaque line inside carbon paper . Envelopes open sequentially write subject 's track information envelope carbon paper serve audit trail . Blinding : Both drug active ingredient placebo provide hospital pharmacy identical seal opaque container , equal weight , similar appearance , tamper-proof . The drug active ingredient container label either Group A Group B head pharmacist assignment keep secret revealed end study . Drugs administer patient seal opaque infusion drip . IVF/ICSI cycle do use standard LLP group . Primary outcome Live birth rate . Secondary outcomes clinical pregnancy rate side effects/tolerability Intralipid infusion .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>Age 2038 year age . Repeated implantation failure 3 fail IVF cycle good quality embryo . Normal transvaginal ultrasonography . Normal hysteroscopy . Normal male female karyotyping . Normal anti cardiolipin antibody IGG , IGM Lupus anticoagulant . Normal thrombophilia screen form protein c , , anti thrombin iii factor v leiden . Written sign informed consent patient participate study . Age 38 year . Less 3 fail IVF cycle . Poor embryo quality . Expected poor ovarian response . Abnormal transvaginal ultrasound finding e.g . endometrial polyps fibroid . Abnormal male female karyotyping . Abnormal hysteroscopic find e.g . endometrial polyp , endometrial hyperplasia , fibroid congenital anomaly . Positive Anticardiolipin antibody Lupus anticoagulant . Positive thrombophilia screen . Allergy soy oil , egg , peanut , peanutbased product active ingredient infusion . Mental condition render patient unable understand nature , scope possible consequence study .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Recurrent implantation failure</keyword>
	<keyword>IVF</keyword>
	<keyword>ICSI</keyword>
	<keyword>Intralipid</keyword>
</DOC>